Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 16Recruiting 7Unknown 5Terminated 5Active not recruiting 5Not yet recruiting 2Withdrawn 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Colorectal Neoplasms 20Rectal Neoplasms 11Colonic Neoplasms 9Neoplasm Metastasis 7Carcinoma, Hepatocellular 6Pancreatic Neoplasms 5Stomach Neoplasms 4Recurrence 2Esophageal Neoplasms 2Adenocarcinoma Of Esophagus 2Peritoneal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Motor Activity 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Esophagogastric Cancer 1Esophageal Squamous Cell Carcinoma 1Clinical Stage I Gastric Cancer AJCC v8 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Borderline Resectable Pancreatic Adenocarcinoma 1Biliary Tract Neoplasms 1Adenocarcinoma 1

Interventions

Carboplatin 33Pemetrexed 25Cisplatin 23Paclitaxel 20Radiotherapy 16Docetaxel 16Gemcitabine 15durvalumab 14Radiosurgery 14pembrolizumab 13Nivolumab 13Erlotinib Hydrochloride 10Taxes 8atezolizumab 7Magnetic Resonance Spectroscopy 7Drug Therapy 6Cyclophosphamide 6Bevacizumab 6Platinum 5Gefitinib 5130-nm albumin-bound paclitaxel 5Etoposide 4Biopsy 4Albumin-Bound Paclitaxel 41,2-diaminocyclohexaneplatinum II citrate 4spartalizumab 3sotorasib 3poly ICLC 3capmatinib 3Surveys and Questionnaires 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Carcinoma, Non-Small-Cell Lung × Oxaliplatin × Clear all
NCT03169738 2025-02-21

QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors

ImmunityBio, Inc.

Phase 1/2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡